Company Filing History:
Years Active: 2023
Title: Roger Cohen - Innovator in Cancer Treatment
Introduction
Roger Cohen is a notable inventor based in Jenkintown, PA (US). He has made significant contributions to the field of cancer treatment, particularly focusing on head and neck cancers. His innovative approach utilizes NKG2A-targeting agents, which have the potential to improve patient outcomes.
Latest Patents
Roger Cohen holds 1 patent related to the treatment of head and neck cancer. This patent describes the use of NKG2A-targeting agents for patients who have previously received treatment with cetuximab. The invention also outlines advantageous combination regimens that enhance the efficacy of these agents in treating cancers.
Career Highlights
Cohen is associated with Innate Pharma, a company dedicated to developing innovative immunotherapies for cancer treatment. His work at Innate Pharma has positioned him as a key player in the advancement of cancer therapies.
Collaborations
Throughout his career, Roger Cohen has collaborated with esteemed colleagues such as Agnes Boyer-Chammard and Pierre Dodion. These partnerships have fostered a collaborative environment that encourages innovation and the development of effective cancer treatments.
Conclusion
Roger Cohen's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient care. His work continues to influence the field of oncology and offers hope for better treatment options for patients with head and neck cancers.